H

Haemonetics Corp
D

HAE

62.950
USD
-0.46
(-0.73%)
مغلق
حجم التداول
45,115
الربح لكل سهم
4
العائد الربحي
-
P/E
25
حجم السوق
3,162,448,485
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    1.785
    (1.34%)
    134.950 USD
    B
    BAX
    0.425
    (1.27%)
    33.840 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    BSX
    BSX
    -0.840
    (-0.80%)
    104.480 USD
    EW
    EW
    -1.380
    (-1.85%)
    73.300 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    MDT
    MDT
    2.000
    (2.27%)
    89.940 USD
    SYK
    SYK
    -3.72
    (-0.96%)
    382.74 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    ZBH
    ZBH
    1.250
    (1.21%)
    104.890 USD
    المزيد
الأخبار
المقالات

العنوان: Haemonetics Corp

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.